When the country's largest retailer concludes that in-store primary-care clinics do not work, the lesson is not about that one company's execution. The lesson is about the underlying unit economics of clinic-based primary care, which defeat scale in a way that does not happen in most retail categories. Volume is supposed to make things cheaper. In healthcare delivery, volume runs straight into a fixed-cost ceiling — physician time, real estate, and reimbursement schedules — that does not yield to procurement. That is the story behind the closures, and it is a much bigger story than the press release implied.
Key takeaways
- Scale advantages do not transfer to clinic-based primary care because the bottleneck is physician time.
- Insurance reimbursement is the price ceiling, and it does not flex with retail volume.
- The Medicare Advantage adjacency is what made the model tempting and what eventually exposed its margin.
- Telehealth and pharmacy-only services likely become the residual delivery model.
Why retail scale does not solve clinic economics
The classic retailer advantage — buy more, pay less — works on goods because goods cost what suppliers will accept. In primary care the marginal cost is a clinician's hour, and a clinician's hour is supply-constrained. Hiring at scale does not lower the wage. If anything it raises it, because every new clinic competes against incumbents for the same scarce pool. The other side of the equation is the price. Reimbursement is set by payers, and the largest payer prices through Medicare schedules that do not adjust for who is delivering the service. That collapses the margin on every visit, and no amount of foot traffic from the supermarket fixes it.
- Wage floor. Clinician supply is the binding constraint on growth.
- Price ceiling. Reimbursement is set by payers, not negotiated by sellers.
- Real estate. Clinic square footage is a fixed cost that does not amortize against retail traffic.
The Medicare Advantage hook that did not pay out
Part of the retail-clinic thesis was that primary-care relationships would feed into Medicare Advantage plans, where the economics could work. That linkage required either owning the plan or contracting with one on attractive terms. Owning a plan brought regulatory complexity that did not fit retail operating culture. Contracting did not work because the plans pay for outcomes, not visits, and outcomes are hard to deliver at the pace clinic traffic demands. The strategic adjacency that made the math look possible turned out to be the part that broke first.
What survives
The likely residual model is pharmacy-anchored care — vaccinations, basic chronic-disease management, and screening — delivered by pharmacists working under standing orders. The economics of that model are different because the labor cost is lower and the visit time is shorter. Telehealth fills in around it for episodic care, with referral to specialists when the case warrants.
What does not survive
Full-service primary-care clinics inside retail boxes are unlikely to come back. The model has been tried, capitalized, scaled, and unwound several times by different operators. Each cycle ends the same way.
How clinic-based care compares to alternative delivery models
The retreat from retail clinics is best understood against the alternatives that are growing.
| Model | Labor cost per visit | Capital intensity | Reimbursement fit |
|---|---|---|---|
| Retail full-service clinic | High (MD/NP time) | Real estate plus equipment | Poor — fee schedules undercut margin |
| Pharmacy-anchored services | Lower (pharmacist hours) | Embedded in existing store | Improving — limited scope codes |
| Telehealth episodic | Low per visit | Software and licensure | Adequate at scale |
| Value-based primary care | High but tied to outcomes | Practice acquisitions | Strong — capitated payment |
The retreat is not a verdict on healthcare innovation. It is a verdict on putting retail scale to work on a problem that does not respond to retail scale.
Frequently asked questions
Could a different operator make this work?
Several have tried. The recurring failure across very different operating cultures suggests the constraint is structural, not managerial. Until the labor supply or the reimbursement structure changes, the model is hard to fix from the operator side.
Does this mean retail health is dead?
No. Pharmacy-anchored and tele-anchored models are still growing. What is dying is the specific bet that supermarket foot traffic plus a physician's office equals profitable primary care.
What happens to communities that relied on these clinics?
Access shrinks. The clinics often opened in markets that did not have many primary-care alternatives, and their closure leaves real gaps. Local hospital systems and federally qualified health centers will absorb part of the load, but not all of it.
The bottom line
The closure of in-store clinics is a lesson in what retail scale can and cannot do. It can move goods. It cannot manufacture clinician hours, and it cannot set reimbursement. Until one of those constraints changes, the model will continue to fail in the same predictable way.
